Abstract
Among the vast array of rodent models of human breast cancer, the carcinogen-induced, i.e., MCA, DMBA, MNU, rat mammary tumor model has received the greatest attention, particularly from those who are interested in the hormonal control of this disease. The popularity of this experimental tumor system stems from the realization that this model closely parallels the human disease, as judged by significant morphological and physiological criteria. For example, carcinogen-induced rat mammary carcinomas appear to arise from the ductal elements of the mammary gland (Russo et al., 1977), and most human breast carcinomas also appear to be of ductal origin (Wellings et al., 1975). A crucial viral component has not been clearly demonstrated in this model (Chopra and Taylor, 1970), nor has such a factor been unequivocally demonstrated in the human disease (McGrath and Soule, 1977). Most of the rat mammary carcinomas induced by chemical carcinogens are hormone (pituitary and ovarian) responsive (Welsch, 1982) as are a significant fraction of human breast carcinomas (Segaloff, 1975). Furthermore, carcinogens such as DMBA and MNU are relatively specific for the mam-mary gland (other organs are not often involved) and a single injection of either one of these carcinogens is tumorigenic in the rat, allowing one to examine separately the initiation and promotional phases of this neo-plastic process (Welsch et al.,1980, 1981).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aschheim, P., 1961, La pseudogestation a repetition chez les rats seniles, C. R. Acad. Sci. 253: 1988–1990.
Aschheim, P., 1976, Aging in the hypothalamic-hypophyseal ovarian axis in the rat, in: Hypothalamus, Pituitary and Aging ( A. V. Everitt and J. A. Burgess, eds.), Charles C. Thomas, Springfield, Illinois, pp. 376–418.
Aylsworth, C. F., Hodson, C. A., Berg, C., Kledzik, G., and Meites, J., 1979, Role of adrenals and estrogen in regression of mammary tumors during postpartum lactation in the rat, Cancer Res. 39: 2436–2439.
Aylsworth, C. F., Hodson, C. A., and Meites, J., 1979, Opiate antagonists can inhibit mammary tumor growth in rats, Proc. Soc. Exp. Biol. Med. 161:18-20.
Aylsworth, C. F., Sylvester, P. W., Leung, F. C., and Meites, J., 1980, Inhibition of mammary tumor growth by dexamethasone in rats in the presence of high serum prolactin levels, Cancer Res. 40: 1863–1866.
Block, V. S., 1961, Untersuchungen uber das genitale altern des rattenweibshens, Gerontologia 5: 55–62.
Butcher, R. L., Collings, W. E., and Fugo, N. W., 1974, Plasma concentration of LH, FSH, prolactin, progesterone, and estradiol-1713 throughout the 4-day estrous cycle of the rat, Endocrinology 94: 1704–1708.
Chan, S. W. C., and Leathem, J. H., 1977, Aging and ovarian steroidogenesis in the rat, J. Gerontol. 32: 395–401.
Chen, H. J., Bradley, C. J., and Meites, J., 1977, Stimulation of growth of carcinogen-induced mammary cancers in rats by thyrotropin-releasing hormone, Cancer Res. 37: 64–66.
Chopra, H., and Taylor, D. J., 1970, Virus particles in rat mammary tumors of varying origin, J. Natl. Cancer Inst. 44: 1141–1147.
Christakos, S., Sinha, D., and Dao, T. L., 1976, Neonatal modification of endocrine func-tions and mammary carcinogenesis in the rat, Brit. J. Cancer 34: 58–63.
Clemens, J. A., and Meites, J., 1971, Neuroendocrine status of old constant estrous rats, Neuroendocrinology 7: 249–256.
Clemens, J. A., and Shaar, C. J., 1972, Inhibition by ergocornine of initiation and growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats: Effect of tumor size, Proc. Soc. Exp. Biol. Med. 139: 659–662.
Clemens, J. A., Welsch, C. W., and Meites, J., 1968, Effects of hypothalamic lesions on incidence and growth of mammary tumors in carcinogen treated rats, Proc. Soc. Exp. Biol. Med. 127: 969–972.
Damassa, D. A., Gilman, D. P., Lu, K. H., Judd, H. L., and Sawyer, C. H., 1980, The twenty-four hour pattern of prolactin secretion in aging female rats, Biol. Reprod. 22: 571–575.
Dao, T. L., 1962, The role of ovarian hormones in initiating the induction of mammary cancer in rats by polynuclear hydrocarbons, Cancer Res. 22: 973–981.
Dao, T. L., and Sunderland, H., 1959, Mammary carcinogenesis by 3-methylcholanthrene. I. Hormonal aspects in tumor induction and growth, J. Natl. Cancer Inst. 23: 567–585.
Dao, T. L., Bock, F. G., and Greiner, M. J., 1960, Mammary carcinogenesis by 3-methylcholanthrene. II. Inhibitory effect of pregnancy and lactation on tumor induction, J. Natl. Cancer Inst. 25: 991–1003.
DeSombre, E. R., Johnson, E. S., and White, W. F., 1976, Regression of rat mammary tumors effected by a gonadoliberin analog, Cancer Res. 36: 3830–3833.
Durbin, P. W., Williams, M. H., Jeung, N., and Arnold, J. S., 1966, Development of spontaneous mammary tumors over the life-span of the female Charles River (Sprague—Dawley) rat: The influence of ovariectomy, thyroidectomy, and adrenalectomy-ovariectomy, Cancer Res. 26: 400–411.
Fayein, N. A., and Aschheim, P., 1980, Age-related temporal changes of levels of circulating progesterone in repeatedly pseudopregnant rats, Biol. Reprod. 23: 616–620.
Fysh, J. M., and Okey, A. B., 1979, Aryl hydrocarbon (benzopyrene) hydroxylase in rat mammary tissue during pregnancy and lactation, Can. J. Physiol. Pharmacol. 57: 112–117.
Heuson, J. C., Legros, N., and Heimann, R., 1972a, Influence of insulin administration on growth of the 7,12-dimethylbenzanthracene-induced mammary carcinoma in intact, oophorectomized and hypophysectomized rats, Cancer Res. 32: 233–238.
Heuson, J. C., Waelbroeck, C., Legros, N., Gallez, G., Robyn, C., and L’Hermite, M., 19726, Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-Br-aergocryptine (CB-154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100A), an estrogen antagonist, Gynecol. Invest. 2: 130–137.
Hodson, C. A., Mioduszewski, R., and Meites, J., 1978a, Effects of catecholaminergic drugs on growth of carcinogen-induced mammary tumors in rats, IRCS Med. Sci. 6: 399.
Hodson, C. A., Simpkins, J. W., and Meites, J., 1978, Effect of brain serotonin reduction on growth of carcinogen-induced mammary tumors in rats, IRCS Med. Sci. 6: 398.
Huang, H. H., and Meites, J., 1975, Reproductive capacity of aging female rats, Neuroendocrinology 17: 289–295.
Huang, H. H., Marshall, S., and Meites, J., 1976, Capacity of old versus young female rats to secrete LH, FSH, and Prolactin, Biol. Reprod. 14: 538–543.
Huang, H. H., Stegar, R. W., Bruni, J. F., and Meites, J., 1978, Patterns of sex steroid and gonadotropin secretion in aging female rats, Endocrinology 103: 1855–1859.
Huggins, O., Briziarelli, G., and Sutton, H., 1959a, Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors, J. Exp. Med. 109: 25–42.
Huggins, C., Grand, L. C., and Brillantes, F. P., 1959b, Critical significance of breast structure in the induction of mammary cancer in the rat, Proc. Natl. Acad. Sci. USA 45: 1294–1300.
Huggins, C., Grand, L. C., and Brillantes, F. P., 1961, Mammary cancer induced by a single feeding of polynuclear hydrocarbons, and its suppression, Nature 189: 204–207.
Huggins, C., Moon, R. C., and Morii, S., 1962, Extinction of experimental mammary cancer. I. Estradiol-1713 and Progesterone, Proc. Natl. Acad. Sci. USA 48: 379–386.
Ingram, D. L., 1959, The vaginal smear of senile laboratory rats, J. Endocrinol. 19: 182–188.
Jabara, A. G., 1967, Effects of progesterone on 9,10-dimethylbenzanthracene-induced mammary tumours in Sprague—Dawley rats, Brit. J. Cancer 21: 418–429.
Jabara, A. G., and Harcourt, A. G., 1970, The effects of progesterone and ovariectomy on mammary tumours induced by 7,12-dimethylbenzanthracene in Sprague—Dawley rats, Pathology 2: 115–123.
Jabara, A. G., and Harcourt, A. G., 1971, Effects of progesterone, ovariectomy and adrenalectomy on mammary tumours induced by 7,12-dimethylbenzanthracene in Sprague—Dawley rats, Pathology 3: 209–214.
Jordan, V. C., Allen, K. E., and Dix, C. J., 1980, Pharmacology of tamoxifen in laboratory animals, Cancer Treat. Rep. 64: 745–759.
Kim, U., and Furth, J., 1960, Relation of mammary tumors to mammotropes. II. Hormone responsiveness of 3-methylcholanthrene induced mammary carcinomas, Proc. Soc. Exp. Biol. Med. 103: 643–645.
Kledzik, G. S., Bradley, C. J., and Meites, J., 1974, Reduction of carcinogen-induced mammary cancer incidence in rats by early treatment with hormones or drugs, Cancer Res. 34: 2953–2956.
Kovacs, K., 1965, Effect of androgenisation on the development of mammary tumours in rats induced by the oral administration of 9,10-dimethyl-1,2-benzanthracene, Brit. J. Cancer 19: 531–537.
Li, C. H., and Yang, W., 1974, The effect of bovine growth hormone on growth of mammary tumors in hypophysectomized rats, Life Sci. 15: 761–764.
Lu, K. H., Hopper, B. R., Vargo, T. M., and Yen, S. S. C., 1979, Chronological changes in sex steroid, gonadotropin, and prolactin secretion in aging female rats displaying different reproductive states, Biol. Reprod. 21: 193–203.
Mandl, A. M., 1961, Cyclical changes in the vaginal smears of senile nulliparous and multiparous rats, J. Endocrinol. 22: 257–268.
McCormick, G. M., and Moon, R. C., 1967, Hormones influencing postpartum growth of 7,12-dimethylbenzanthracene rat mammary tumors, Cancer Res. 27: 626–631.
McGrath, C. M., and Soule, H. D., 1977, An inquiry into the involvement of nonhuman breast cancer viruses in the human disease: Virus expression in malignant breast ductal stem cells, in: Origins of Human Cancer, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp. 1287–1303.
Meites, J., and Huang, H. H., 1976, Relation of the neuroendocrine system to loss of reproductive function in aging rats, in: Neuroendocrine Regulation of Fertility ( T. C. Anand Kumar, ed.), Karger, Basel Press, New York, pp. 246–258.
Moon, H. D., Simpson, M. E., and Evans, H. M., 1952, Inhibition of methylcholanthrene carcinogenesis by hypophysectomy, Science 116: 331.
Muhlbock, O., and Boot, L. M., 1959, Induction of mammary cancer in mice without the mammary tumor agent by isografts of hypophysis, Cancer Res. 19: 402–412.
Nagasawa, H., and Yanai, R., 1970, Effects of prolactin or growth hormone on growth of carcinogen-induced mammary tumors of adreno-ovariectomized rats, Int. J. Cancer 6: 488–495.
Nagasawa, H., and Yanai, R., 1974, Frequency of mammary cell division in relation to age: Its significance in the induction of mammary tumors by carcinogen in rats, J. Natl. Cancer Inst. 52: 609–610.
Newman, W. C., and Moon, R. C., 1968, Chemically induced mammary cancer in rats with altered thyroid function, Cancer Res. 28: 864–868.
Noble, R. L., and Cutts, J. H., 1959, Mammary tumors of the rat: A review, Cancer Res. 19: 1125–1139.
Noble, R. L., and Walters, J. H., 1954, The effect of hypophysectomy on 9,10-dimethyl- 1,2-benzanthracene induced carcinogenesis, Proc. Amer. Assoc. Cancer Res. 1: 35.
Pearson, O. H., Llerena, O., Llerena, L., Molina, A., and Butler, T., 1969, Prolactindependent rat mammary cancer: A model for man? Trans. Assoc. Am. Physicians 82: 225–238.
Quadri, S. K., Kledzik, G. S., and Meites, J., 1973, Effects of L-dopa and methyl-dopa on growth of mammary cancers in rats, Proc. Soc. Exp. Biol. Med. 142: 759–761.
Riegle, G. D., and Miller, A. E., 1978, Age effects on the hypothalamic-pituitary-gonadal control system in the rat, Adv. Exp. Med. Biol. 113: 159–178.
Russo, J., and Russo, I. H., 1978, DNA labelling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis, J. Natl. Cancer Inst. 61: 1451–1459.
Russo, J., and Russo, I. H., 1980, Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis, Cancer Res. 40: 2677–2687.
Russo, J., Saby, J., Isenberg, W., and Russo, I. H., 1977, Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenzanthracene, J. Natl. Cancer Inst. 59: 435–445.
Sakamoto, S., Imamura, Y., Sassa, S., and Okamoto, R., 1979, DMBA induced mammary tumor and hormone environment in the rat during pregnancy, postpartum, and long term lactation, Toxicol. Lett. 4: 237–240.
Segaloff, A., 1975, Hormonal therapy of breast cancer, Cancer Treat. Rev. 2: 129–135.
Shaar, C. J., Euker, J. S., Riegle, G. D., and Meites, J., 1975, Effects of castration and gonadal steroids on serum luteinizing hormone and prolactin in old and young rats, J. E ndocrinol. 66: 45–51.
Shellabarger, C. L., 1981, Pituitary and steroid hormones in radiation-induced mammary tumors, in: Hormones and Breast Cancer, Banbury Report #8 ( M. C. Pike, P. K. Siiteri, and C. W. Welsch, eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp. 339–351.
Sinha, D. K., and Dao, T. L., 1980, Induction of mammary tumors in aging rats by 7,12dimethylbenzanthracene: Role of DNA synthesis during carcinogenesis, J. Natl. Cancer Inst. 64: 519–521.
Sinha, D., Cooper, D., and Dao, T. L., 1973, The nature of estrogen and prolactin effect on mammary tumorigenesis, Cancer Res. 33: 411–414.
Steger, R. W., Huang, H. H., and Meites, J., 1979, Relation of aging to hypothalamic LHRH content and serum gonadal steroids in female rats, Proc. Soc. Exp. Biol. Med. 161: 251–254.
Sterental, A., Dominguez, J. M., Weissman, C., and Pearson, O. H., 1963, Pituitary role in the estrogen dependency of experimental mammary cancer, Cancer Res. 23: 481–484.
Talwalker, P. K, Meites, J., and Mizuno, H., 1964, Mammary tumor induction by estrogen or anterior pituitary hormones in ovariectomized rats given 7,12-dimethylbenzanthracene, Proc. Soc. Exp. Biol. Med. 116: 531–534.
Tamarkin, L., Cohen, M., Roselle, D., Rerchert, C., Lippman, M., and Chabner, B., 1981, Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenzanthracene-induced mammary tumors in the rat, Cancer Res. 41: 4432–4436.
Terenius, L., 1971, Effect of anti-oestrogens on initiation of mammary cancer in the female rat, Eur. J. Cancer 7: 65–70.
Wellings, S. R., Jensen, H. M., and Marcum, R. G., 1975, An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions, J. Natl. Cancer Inst. 55: 231–273.
Welsch, C. W., 1982, Hormones and murine mammary tumorigenesis: An historical perspective, in: Hormonal Regulation of Experimental Mammary Tumors ( B. S. Leung, ed.), Eden Press, Philadelphia, pp. 1–30.
Welsch, C. W., and Gribler, C., 1973, Prophylaxis of spontaneously developing mammary carcinoma in C3H/HeJ female mice by suppression of prolactin, Cancer Res. 33: 2939–2946.
Welsch, C. W., and Meites, J., 1969, Effects of a norethynodrel-mestranol combination (Enovid) on development and growth of carcinogen-induced mammary tumors in female rats, Cancer 23: 601–607.
Welsch, C. W., and Meites, J., 1970, Effects of reserpine on development of 7,12-dime-thylbenzanthracene induced mammary tumors in female rats, Experientia 26: 1133–1134.
Welsch, C. W., and Nagasawa, H., 1977, Prolactin and murine mammary tumorigenesis: A review, Cancer Res. 37: 951–963.
Welsch, C. W., Clemens, J. A., and Meites, J., 1968, Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenzanthracene-induced mammary tumors in rats, J. Natl. Cancer Inst. 41: 465–471.
Welsch, C. W., Clemens, J. A., and Meites, J., 1969, Effects of hypothalamic and amygdaloid lesions on development and growth of carcinogen-induced mammary tumors in the female rat, Cancer Res. 29: 1541–1549.
Welsch, C. W., Jenkins, T. W., and Meites, J., 1970a, Increased incidence of mammary tumors in the female rat grafted with multiple pituitaries, Cancer Res. 30: 1024–1029.
Welsch, C. W., Nagasawa, H., and Meites, J., 19706, Increased incidence of spontaneous mammary tumors in female rats with induced hypothalamic lesions, Cancer Res. 30: 2310–2313.
Welsch, C. W., Iturri, G., and Meites, J., 1973, Comparative effects of hypophysectomy, ergocornine and ergocornine-reserpine treatments on rat mammary carcinoma, Int. J. Cancer 12: 206–212.
Welsch, C. W., Brown, C. K., Goodrich-Smith, M., Van, J., Denenberg, B., Anderson, T. M., and Brooks, C. L., 1979, Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion, J. Natl. Cancer Inst. 63: 1211–1214.
Welsch, C. W., Brown, C. K., Goodrich-Smith, M., Chiusano, J., and Moon, R. C., 1980, Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague—Dawley rats, Cancer Res. 40: 3095–3098.
Welsch, C. W., Goodrich-Smith, M., and Brown, C. K., 1981, The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: A reappraisal, Breast Cancer Res. Treat. 1: 225–232.
Welsch, C. W., Goodrich-Smith, M., Brown, C. K., Mackie, D., and Johnson, D., 1982, 2-Bromo-a-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): A comparison, Oncology 39: 88–92.
Wilkes, M. M., Lu, K. H., Fulton, S. L., and Yen, S. S. C., 1978, Hypothalamic-pituitaryovarian interactions during reproductive senescence in the rat, Adv. Exp. Med. Biol. 113: 127–147.
Yokoro, K., Nakano, M., Ito, A., Nagao, K., Kodama, Y., and Hamada, K., 1977, Role of prolactin in rat mammary carcinogenesis: Detection of carcinogenicity of low dose carcinogens and of persisting dormant cancer cells, J. Natl. Cancer Inst. 58: 1777–1783.
Yoshida, H., Fukunishi, R., Kato, Y., and Matsumoto, K., 1980, Progesterone-stimulated growth of mammary carcinomas induced by 7,12-dimethylbenzanthracene in neonatally androgenized rats, J. Natl. Cancer Inst. 65: 823–828.
Young, S., 1961, Induction of mammary carcinoma in hypophysectomized rats treated with 3-methylcholanthrene, estradiol-1713, progesterone and growth hormone, Nature 190: 356–357.
Young, S., Baker, R. A., and Helfenstein, J. E., 1965, The effects of androgens on induced mammary tumours in rats, Brit. J. Cancer 19: 155–159.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Welsch, C.W., Aylsworth, C.F. (1983). Relation of the Neuroendocrine System to the Development of Mammary Tumors in Rats during Aging. In: Meites, J. (eds) Neuroendocrinology of Aging. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4523-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4523-7_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4525-1
Online ISBN: 978-1-4684-4523-7
eBook Packages: Springer Book Archive